Micro Cap Massively Bid Up Before Opening Bell

A Florida-based medical device company is finding tremendous success so far during Wednesday’s premarket after the company reported a year-over-year increase in Q4 revenue and said it remains on track to reach its goal of reaching break-even or profitability within its current operations in 2024, according to a release this morning.

Traders were extremely excited about the release as they quickly bid up shares of INVO BioScience Inc. (Nasdaq:INVO). At the time of writing, the live bid leading up to the opening bell was $2.03/share (+167.11% implied open for sellers). It should be an exciting session for this micro cap!

INVO Bioscience Inc operates as a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility.

Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com’s content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

]]>